Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Cancer Res1
Search Results
Sort by
- BookTony Harris, editor.Contents:
Introduction to adherens junctions: from molecular mechanisms to tissue development and disease
How AJs evolved
Evolution of the cadherin-catenin complex
How cadherins and catenins interact to assemble AJs
Three-dimensional structure of the cadherin-catenin complex
Biophysics of cadherin adhesion
Adherens junction assembly
How AJs interface with other cellular machinery
Cytoskeleton and classical cadherin adhesions
Immunoglobulin superfamily receptors and adherens junctions
Signaling from the adherens junction
Adherens junction turnover: regulating adhesion through cadherin endocytosis, degradation, and recycling
How AJs affect cell behaviour and multicellular development
Adherens junctions during cell migration
Adherens junctions and cadherins in Drosophilia development
Adherens junctions in C. elegans embryonic morphogenesis
Cadherin function during xenopus gastrulation
Adherens junctions in mammalian development, homeostasis and disease: lessons from mice
How AJs affect tissue homeostasis and disease
Adherens junctions and stem cells
Adherens junctions and cancer
Adherens junctions and pathogen entry.Digital Access Springer 2012 - ArticleNelson JA, Harris BA, Decker WJ, Farquhar D.Cancer Res. 1977 Nov;37(11):3970-3.Methotrexate in human plasma at a concentration as low as 0.01 microgram/ml can be assayed with the use of high-pressure-liquid chromatography and a fluorescence detection system. Methotrexate is oxidized stoichiometrically to 2,4-diaminopteridine-6-carboxylic acid, a fluorescent product that is separable from other fluorescent materials in plasma with the use of an octadecylsilane (reversed phase) column. The detector response is linear over the range of 0.01 to 10 microgram/ml. Neither folic acid nor citrovorum factor interferes with the analysis. N-((4-([2,4-Dihydroxy-6-pteridyl)methyl]-amino)benzoyl))glutamic acid may be used as an internal standard, since it can be extracted from plasma and oxidized like methotrexate. The procedure is rapid (about 30 min) and should be a useful method for monitoring methotrexate plasma concentrations.